Twist Bioscience Stock Price

3.97 (3.33%)


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Twist Bioscience Corporation TWST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
3.97 3.33% 123.05 16:05:51
Open Price Low Price High Price Close Price Prev Close
118.58 117.68 123.50 123.05 119.08
Bid Price Ask Price Spread News
123.05 124.00 0.95 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,314 417,291 $ 121.61 $ 50,747,218 - 53.81 - 214.07
Last Trade Time Type Quantity Stock Price Currency
16:24:13 7 $ 123.50 USD


Draw Mode:

Twist Bioscience Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.02B 48.89M 46.79M $ 90.10M $ - -3.69 -43.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -152.40k 3.30%

more financials information »

Twist Bioscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TWST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week121.40123.50106.69115.43462,1021.651.36%
1 Month131.70133.1242106.69119.83387,449-8.65-6.57%
3 Months117.94136.8784.23109.83559,5905.114.33%
6 Months166.74202.1884.23127.66782,516-43.69-26.2%
1 Year57.80214.0753.81120.07709,29465.25112.89%
3 Years13.00214.0712.3879.96470,872110.05846.54%
5 Years13.00214.0712.3879.96470,872110.05846.54%

Twist Bioscience Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Your Recent History
Twist Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.